• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重发热伴血小板减少综合征患者实验室标志物的动力学及其预后意义:来自综合分析的见解。

Kinetics and Prognostic Significance of Laboratory Markers in Patients With Severe Fever With Thrombocytopenia Syndrome: Insight From a Comprehensive Analysis.

机构信息

Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Infect Dis. 2024 Jun 14;229(6):1845-1855. doi: 10.1093/infdis/jiad426.

DOI:10.1093/infdis/jiad426
PMID:37804100
Abstract

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with significant mortality. Identifying prognostic factors that influence patient outcomes is crucial for effective clinical management. In this study, we assessed the dynamic changes of laboratory markers and their association with outcomes in 93 SFTS patients. We found that age and hypertension were significantly associated with poor outcomes in SFTS patients. The deceased group exhibited lower platelet counts, elevated liver and kidney function markers, coagulation profiles, inflammatory markers, and cytokines compared to the survival group. Kinetic analysis showed that these markers gradually normalized in the survival group, while they remained persistently abnormal in the deceased group. Furthermore, hypertension, elevated aspartate aminotransferase, procalcitonin, and interleukin 10 were identified as independent risk factors for predicting poor prognosis of SFTS patients. These findings provide valuable insights into the prognostic significance of laboratory markers and highlight the importance of early identification of high-risk SFTS patients.

摘要

严重发热伴血小板减少综合征(SFTS)是一种具有显著死亡率的新发传染病。确定影响患者预后的预后因素对于有效的临床管理至关重要。在这项研究中,我们评估了 93 例 SFTS 患者的实验室标志物的动态变化及其与结局的关系。我们发现,年龄和高血压与 SFTS 患者的不良结局显著相关。死亡组的血小板计数较低,肝肾功能标志物、凝血谱、炎症标志物和细胞因子水平较存活组升高。动态分析显示,这些标志物在存活组中逐渐恢复正常,而在死亡组中仍持续异常。此外,高血压、天门冬氨酸氨基转移酶升高、降钙素原和白细胞介素 10 被确定为预测 SFTS 患者预后不良的独立危险因素。这些发现提供了实验室标志物预后意义的有价值的见解,并强调了早期识别高危 SFTS 患者的重要性。

相似文献

1
Kinetics and Prognostic Significance of Laboratory Markers in Patients With Severe Fever With Thrombocytopenia Syndrome: Insight From a Comprehensive Analysis.严重发热伴血小板减少综合征患者实验室标志物的动力学及其预后意义:来自综合分析的见解。
J Infect Dis. 2024 Jun 14;229(6):1845-1855. doi: 10.1093/infdis/jiad426.
2
MCP-3 as a prognostic biomarker for severe fever with thrombocytopenia syndrome: a longitudinal cytokine profile study.MCP-3 作为发热伴血小板减少综合征严重程度的预后生物标志物:一项纵向细胞因子谱研究。
Front Immunol. 2024 May 15;15:1379114. doi: 10.3389/fimmu.2024.1379114. eCollection 2024.
3
Difference in hematocrit and plasma albumin levels as an early biomarker of severity and prognosis in patients with severe fever and thrombocytopenia syndrome.血细胞比容和血浆白蛋白水平的差异作为严重发热伴血小板减少综合征患者严重程度和预后的早期生物标志物。
J Med Virol. 2024 Oct;96(10):e29941. doi: 10.1002/jmv.29941.
4
Blood urea nitrogen to albumin ratio is a novel predictor of fatal outcome for patients with severe fever with thrombocytopenia syndrome.血尿素氮与白蛋白比值是发热伴血小板减少综合征重症患者死亡结局的一个新的预测指标。
J Med Virol. 2024 Jun;96(6):e29731. doi: 10.1002/jmv.29731.
5
Correlation between thrombocytopenia and host response in severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征中血小板减少与宿主反应的相关性。
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008801. doi: 10.1371/journal.pntd.0008801. eCollection 2020 Oct.
6
Procalcitonin levels in severe fever with thrombocytopenia syndrome patients: a retrospective investigation in Anhui, China.严重发热伴血小板减少综合征患者降钙素原水平:中国安徽的一项回顾性调查。
J Infect Dev Ctries. 2024 Aug 31;18(8):1265-1273. doi: 10.3855/jidc.18087.
7
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
8
Fibrinogen-to-prealbumin and C-reactive protein-to-prealbumin ratios as prognostic indicators in severe fever with thrombocytopenia syndrome.纤维蛋白原/前白蛋白比值和 C 反应蛋白/前白蛋白比值作为重症发热伴血小板减少综合征的预后指标。
Front Cell Infect Microbiol. 2024 Jun 10;14:1397789. doi: 10.3389/fcimb.2024.1397789. eCollection 2024.
9
Acute kidney injury as a prognostic marker in severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征中急性肾损伤作为预后标志物。
Sci Rep. 2024 Sep 4;14(1):20651. doi: 10.1038/s41598-024-71438-8.
10
A nomogram including admission serum glycated albumin/albumin ratio to predict mortality in patients with severe fever with thrombocytopenia syndrome.包含入院时糖化血清白蛋白/白蛋白比值的列线图预测重症发热伴血小板减少综合征患者的死亡率。
BMC Infect Dis. 2024 Aug 23;24(1):858. doi: 10.1186/s12879-024-09752-9.

引用本文的文献

1
Prediction of Mortality by Clinical Laboratory Parameters in Severe Fever with Thrombocytopenia Syndrome: A Meta-Analysis.通过临床实验室参数预测发热伴血小板减少综合征患者的死亡率:一项Meta分析
Trop Med Infect Dis. 2025 Jul 9;10(7):193. doi: 10.3390/tropicalmed10070193.
2
Clinical Value of Complement C3a, C5a, and sC5b-9 in Evaluating the Severity of Patients with Severe Fever with Thrombocytopenia Syndrome.补体C3a、C5a和sC5b-9在评估严重发热伴血小板减少综合征患者病情严重程度中的临床价值
J Inflamm Res. 2025 Jul 10;18:9001-9014. doi: 10.2147/JIR.S520425. eCollection 2025.
3
Retrospective Analysis of Severe Fever With Thrombocytopenia Syndrome and Construction of a Nomogram Prediction Model for Mortality Risk Factors.
发热伴血小板减少综合征回顾性分析及死亡危险因素列线图预测模型构建
Open Forum Infect Dis. 2025 Jun 2;12(7):ofaf318. doi: 10.1093/ofid/ofaf318. eCollection 2025 Jul.
4
: A review of epidemiology, clinical characteristics, pathophysiology, treatment and prevention.流行病学、临床特征、病理生理学、治疗与预防综述
Virulence. 2025 Dec;16(1):2520343. doi: 10.1080/21505594.2025.2520343. Epub 2025 Jun 17.
5
Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study.发热伴血小板减少综合征患者活化部分凝血活酶时间的动态变化及其与死亡率的相关性:一项回顾性队列研究
PLoS Negl Trop Dis. 2025 May 22;19(5):e0013106. doi: 10.1371/journal.pntd.0013106. eCollection 2025 May.
6
Establishment and validation of a clinical risk scoring model to predict fatal risk in SFTS hospitalized patients.建立并验证一个临床风险评分模型,以预测发热伴血小板减少综合征住院患者的死亡风险。
BMC Infect Dis. 2024 Sep 13;24(1):975. doi: 10.1186/s12879-024-09898-6.